---
title: "Matinas BioPharma surges 37% in regular trading on volume spike"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293943308.md"
description: "Matinas BioPharma (MTNB) jumped 37% during regular trading, triggering a 5-minute surge alert."
datetime: "2026-07-27T13:50:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293943308.md)
  - [en](https://longbridge.com/en/news/293943308.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293943308.md)
generator: "portal-rs"
---

# Matinas BioPharma surges 37% in regular trading on volume spike

Matinas 生物制药 (MTNB.US) 盘中急涨**37.41%**，现报**0.3317 美元**。

### Related Stocks

- [MTNB.US](https://longbridge.com/en/quote/MTNB.US.md)

## Related News & Research

- [Is Royalty Pharma (RPRX) Undervalued On Its $100 Million Zealand Pharma Royalty Deal?](https://longbridge.com/en/news/296647266.md)
- [Did Abbott’s Q2 Beat and Profit Hike Just Shift Abbott Laboratories’ (ABT) Investment Narrative?](https://longbridge.com/en/news/296546525.md)
- [Founder Led Stocks Retail Investors Are Watching For Long Term Growth](https://longbridge.com/en/news/296452443.md)
- [Diversify Advisory Services LLC Buys New Holdings in Regeneron Pharmaceuticals, Inc. $REGN](https://longbridge.com/en/news/296585791.md)
- [Canton Hathaway LLC Has $1.05 Million Stock Holdings in Eli Lilly and Company $LLY](https://longbridge.com/en/news/296450496.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**